Sitemap

November 21, 2017 Articles

Filter by Available Specialty
  1. C. difficile persists most frequently in floor corners after disinfection
  2. 2 studies underscore high CV risk in primary aldosteronism, despite treatment
  3. ACIP recommends third MMR dose during mumps outbreaks
  4. ACP: Improving health care price transparency ‘vital’
  5. ACR asks CMS to 'remove barriers' between small practices, alternative payment models
  6. ALLHAT
  7. Approach to ECG Interpretation
  8. ARBITER 6-HALTS
  9. ARISTOTLE Trial
  10. As Madagascar plague outbreak loosens grip, concerns linger
  11. ASCEND-HF Trial
  12. ASCERT Trial
  13. ATHENA Trial
  14. ATLAS ACS 2-TIMI 51 Trial
  15. Atrial Tachycardia - Paroxysmal
  16. BLOG: November, again!
  17. BLOG: Some early postop issues just need a tincture of time
  18. Bone loss remains elevated 5 years after RYGB vs. sleeve gastrectomy
  19. Causes of immunotherapy-related side effects in cancer require more research
  20. CDC: Raw milk contaminated with dangerous bacteria sold in four states
  21. Cholera: A disease with unending epidemics
  22. Considerations for patients with Ehlers-Danlos syndromes undergoing surgery
  23. Current guidelines underestimate statin eligibility after MI in young adults
  24. Decades later, still no vaccine or treatment for West Nile virus
  25. DECIDE-LVAD: Decision-making tool improves decision quality among LVAD candidates
  26. Discontinuity of care increases risk for unplanned hospital admissions among elderly patients
  27. DT MedTech receives 510(k) FDA clearance for total ankle replacement system
  28. Durable change in antibiotic prescribing requires long-term interventions
  29. Endoluminal bypass shows promise for PAD
  30. Ethanol lock therapy does not prevent treatment failure from CLABSIs
  31. FDA accepts NDA for Aristada dispersion product
  32. FDA announces policy framework to develop regenerative medicine products
  33. FDA approves first two-drug HIV regimen, Juluca
  34. FDA approves herpes zoster vaccine Shingrix
  35. FDA issues guidance on developing generic abuse-deterrent opioids
  36. H1N1 may double risk for diabetes
  37. Hemlibra prophylaxis reduces treated bleeds for certain patients with hemophilia A
  38. HIV care outcomes improve among MSM
  39. Hormonal birth control may increase risk for suicide
  40. HPV testing more effective than Pap smear for detecting cervical cancer
  41. ID specialists ponder universal HCV screening
  42. Immuron receives patent claim for NASH treatment development
  43. Infant vaccination rates remain high despite racial, insurance disparities
  44. Influenza vaccination rates unchanged after ACIP withdraws LAIV recommendation
  45. Insurance disparities, tumor types drive lower colon cancer survival in blacks
  46. Intranasal tear neurostimulation increases acute tear production
  47. Lesions on MRI absent symptoms, history may yield false spondyloarthritis diagnosis
  48. Low skeletal muscle mass improves after successful HCV treatment
  49. Majority of women prefer annual screening mammograms, despite potential ‘harms’
  50. Many cancers associated with modifiable risk factors
  51. MRSA ventilator-associated pneumonia: Myth or reality?
  52. New single-dose RSV immunoprophylaxis safe, effective in preterm infants
  53. New York law improves HCV screening among baby boomers
  54. Oral insulin pill ineffective for delaying, preventing type 1 diabetes progression
  55. Pediatric Constipation Presents with Added Levels of Complex Care
  56. Physical activity linked to mood, anxiety levels
  57. Primary prevention improves colorectal cancer survival over early detection
  58. RNA blood test for diagnosing IBD, IBS launched
  59. Second Sight reports $6.7 million quarterly net loss
  60. Should people at low risk for HCV infection be screened for the virus?
  61. Study: Spectacle wearers liked wearing contacts while choosing glasses
  62. Tdap vaccinations in pregnant women jump more than 50%
  63. Teen alcohol, drug dependence linked to poor life outcomes in adulthood
  64. Thyroid cancer increases CVD morbidity risk
  65. Topical patidegib granted FDA breakthrough, orphan statuses for Gorlin syndrome
  66. VIDEO: Atacicept is a 'potential, exciting' treatment for lupus
  67. VIDEO: Percutaneous posterior stabilization of L1 to L5, percutaneous L3 biopsy in a spinal metastasis
  68. Working with clinical trials a common theme for KOL migration into industry
  69. Xen gel stent ‘transformative’ to glaucoma practice